SciELO - Scientific Electronic Library Online

 
vol.23 issue5Cardiac Myxomas author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Arquivos de Medicina

On-line version ISSN 2183-2447

Abstract

LOPES, Isabel; ZENHA, Horácio; COSTA, Horácio  and  BARROSO, João. Osteonecrosis of the Jaw Associated With Use of Bisphosphonates. Arq Med [online]. 2009, vol.23, n.5, pp.181-185. ISSN 2183-2447.

Bisphosphonates have been introduced in the medical community as a possible therapy in diseases with high rate of resorption. A few years later became first-line treatment in osteoporosis. Osteonecrosis of the Jaw Associated with the use of Bisphosphonates is a relatively new clinical entity. This severe secondary pathology affects the quality of life, producing significant morbidity. The authors present a case of Osteonecrosis of the Jaw Associated with the use of Bisphosphonates, developed after dental extraction due to tooth infection in a 64 year-old male patient with metastatic prostate cancer, submitted to chemotherapy and bisphosphonate intravenous treatment. The diagnosis was confirmed by the complementary diagnostic tests carried out. The therapeutic orientation was towards the conservative treatment using antibiotics and limited curettage, with good clinical outcome. They also review the aetiology, diagnosis and treatment options. Osteonecrosis of the Jaw Associated with the use of Bisphosphonates is a severe disease, previously unknown and difficult to treat, which should be prevented in patients receiving bisphosphonates. The use of bisphosphonates is increasing and therefore the detailed knowledge of all potential serious side effects is imperative.

Keywords : osteonecrosis; jaw; bisphosphonates.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License